Epstein Secrets

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

it would still launch an investigation into the incident. Radical Cleric Seeks To Reimpose Islamic Law In Afghanistan. The New York Times (10/22, Zucchino, Rahim, Huylebroek, 18.61M) reports in Herat, Afghanistan, "religious vigilantes loyal to a local cleric patrol the streets, routinely detaining and

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

o Reimpose Islamic Law In Afghanistan. The New York Times <https://vvwvv.nytimes.com/2020/10/22/world/asia/afghanistan-cleric-shariah.html> (10122, Zucchino, Rahim, Huylebroek, 18.61M) reports in Herat, Afghanistan, "religious vigilantes loyal to a local cleric patrol the streets, routinely detaining and

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

it would still launch an investigation into the incident. Radical Cleric Seeks To Reimpose Islamic Law In Afghanistan. The New York Times (10/22, Zucchino, Rahim, Huylebroek, 18.61M) reports in Herat, Afghanistan, "religious vigilantes loyal to a local cleric patrol the streets, routinely detaining and